易聯眾(300096.SZ)孫公司擬與微醫集團簽訂560萬元南平健共體項目採購合同
格隆匯12月11日丨易聯眾(300096.SZ)公佈,公司控股孫公司福建易聯眾醫衞信息技術有限公司(“醫衞公司”)擬與微醫集團(浙江)有限公司(“微醫集團”)簽訂《南平健共體項目採購合同》,由醫衞公司向微醫集團提供南平健共體項目相關軟件系統,合同總金額為人民幣560萬元。
此次公司與微醫集團簽署的《南平健共體項目採購合同》主要內容如下:
甲方:微醫集團(浙江)有限公司;乙方:福建易聯眾醫衞信息技術有限公司
合作內容:由甲方向乙方購買南平健共體項目相關軟件系統,包括家庭醫生簽約服務管理平台、基層醫療衞生信息系統、村衞生所管理信息系統的拓展應用和互聯互通支撐。交付方式:合同生效後,乙方在十個工作日內開始配合甲方進行接口開發、部署、安裝、調試、聯調等工作,併為甲方人員提供必要的技術支持和產品培訓。此次合作價格總額為人民幣560萬元。
上述關聯交易屬於正常的、必要的商業交易行為,對公司的獨立性不會產生影響。交易價格是參照市場價格,經雙方協商確定,實行市場定價,價格公允,不存在利用關聯方關係損害上市公司利益的行為,也不存在損害公司合法利益及向關聯方輸送利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.